Federated Hermes’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.3K Buy
+1,390
New +$11K ﹤0.01% 1768
2024
Q2
– Sell
-77
Closed -$1.23K – 2118
2024
Q1
$1.23K Buy
+77
New +$1.25K ﹤0.01% 1947
2023
Q4
– Sell
-697
Closed -$10.2K – 2177
2023
Q3
$10.2K Sell
697
-360
-34% -$6.09K ﹤0.01% 1825
2023
Q2
$18K Sell
1,057
-181
-15% -$2.66K ﹤0.01% 1787
2023
Q1
$17.3K Buy
+1,238
New +$13.2K ﹤0.01% 1824

Other funds holding RCEL

Federated Hermes's RCEL Position: Q3 2026 in Review

Federated Hermes opened a new position in Avita Medical (RCEL) in Q3 2026: 1,390 shares worth $16.3K. The stake represents ﹤0.01% of the portfolio and ranks #1768 among its holdings. This is a return to the name: Federated Hermes previously reported a position in RCEL as recently as Q1 2024.

Federated Hermes first reported a position in RCEL in Q1 2023 and has held it in 5 quarters since. The position peaked at $18K in Q2 2023. 89 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • Federated Hermes held 1,390 shares of Avita Medical worth $16.3K as of Q3 2026.
  • Avita Medical was a new Federated Hermes position in Q3 2026.
  • Avita Medical made up ﹤0.01% of Federated Hermes's portfolio in Q3 2026, its #1768 holding.
  • Federated Hermes first reported a position in Avita Medical in Q1 2023 and has held it in 5 quarters since.
  • Federated Hermes's Avita Medical position peaked at $18K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.